UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,253,000 | -95.4% | 50,000 | -95.2% | 0.14% | -96.3% |
| Q1 2020 | $48,999,000 | -26.4% | 1,032,636 | +11.2% | 3.65% | -10.2% |
| Q4 2019 | $66,575,000 | +18.4% | 929,036 | -35.0% | 4.06% | -27.0% |
| Q3 2019 | $56,214,000 | -62.4% | 1,428,202 | -25.3% | 5.56% | -47.4% |
| Q2 2019 | $149,386,000 | +26.1% | 1,911,529 | -3.7% | 10.57% | +41.4% |
| Q1 2019 | $118,433,000 | +116.7% | 1,985,460 | +4.7% | 7.48% | +86.0% |
| Q4 2018 | $54,649,000 | +43.7% | 1,896,226 | +81.4% | 4.02% | +96.2% |
| Q3 2018 | $38,030,000 | -3.7% | 1,045,065 | 0.0% | 2.05% | -19.6% |
| Q2 2018 | $39,503,000 | +60.8% | 1,045,065 | 0.0% | 2.55% | +13.5% |
| Q1 2018 | $24,559,000 | – | 1,045,065 | – | 2.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |